Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Impact in
- Oncology 1.3k
Classified as
Countries where authors are citing Fulminant Myocarditis with Combination Immune Checkpoint Blockade
This map shows the geographic impact of Fulminant Myocarditis with Combination Immune Checkpoint Blockade. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulminant Myocarditis with Combination Immune Checkpoint Blockade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulminant Myocarditis with Combination Immune Checkpoint Blockade more than expected).
Fields of papers citing Fulminant Myocarditis with Combination Immune Checkpoint Blockade
This network shows the impact of Fulminant Myocarditis with Combination Immune Checkpoint Blockade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
About Fulminant Myocarditis with Combination Immune Checkpoint Blockade
This paper, published in 2016, received 1.9k indexed citations . Written by Douglas Buckner Johnson, Justin Micah Balko, Margaret Compton, Spyridon G. Chalkias, Joshua Gorham, Yaomin Xu, Mellissa J. Hicks, Igor J. Puzanov, Matthew R. Alexander and Tyler L. Bloomer covering the research area of Oncology. It is primarily cited by scholars working on Oncology (1.3k citations), Cardiology and Cardiovascular Medicine (652 citations), Immunology (65 citations), Pulmonary and Respiratory Medicine (50 citations) and Toxicology (35 citations). Published in New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1056/nejmoa1609214.